AbbVie Net Worth 2010-2019 | ABBV

Interactive chart of historical net worth (market cap) for AbbVie (ABBV) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. AbbVie net worth as of June 14, 2019 is $116.33B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $116.330B $32.753B
AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $371.947B 17.04
Pfizer (PFE) United States $237.743B 13.88
Merck (MRK) United States $213.129B 18.35
Novartis AG (NVS) Switzerland $206.791B 17.87
Novo Nordisk (NVO) Denmark $124.522B 20.72
Eli Lilly (LLY) United States $108.481B 20.13
Sanofi (SNY) France $106.019B 13.07
AstraZeneca (AZN) United Kingdom $100.480B 11.57
GlaxoSmithKline (GSK) United Kingdom $99.522B 12.62
Bristol-Myers Squibb (BMY) United States $77.794B 11.49